A. EKİN Et Al. , "The retrospective evaluation of efficacy and safety data after switching from originator rituximab to biosimilar rituximab (CT-P10) in patients diagnosed with systemic lupus erythematosus: a single-center experience," European Review for Medical and Pharmacological Sciences , vol.28, no.10, pp.3513-3522, 2024
EKİN, A. Et Al. 2024. The retrospective evaluation of efficacy and safety data after switching from originator rituximab to biosimilar rituximab (CT-P10) in patients diagnosed with systemic lupus erythematosus: a single-center experience. European Review for Medical and Pharmacological Sciences , vol.28, no.10 , 3513-3522.
EKİN, A., MISIRCI, S., COŞKUN, B. N., YAĞIZ, B., DALKILIÇ, H. E., & PEHLİVAN, Y., (2024). The retrospective evaluation of efficacy and safety data after switching from originator rituximab to biosimilar rituximab (CT-P10) in patients diagnosed with systemic lupus erythematosus: a single-center experience. European Review for Medical and Pharmacological Sciences , vol.28, no.10, 3513-3522.
EKİN, ALİ Et Al. "The retrospective evaluation of efficacy and safety data after switching from originator rituximab to biosimilar rituximab (CT-P10) in patients diagnosed with systemic lupus erythematosus: a single-center experience," European Review for Medical and Pharmacological Sciences , vol.28, no.10, 3513-3522, 2024
EKİN, ALİ Et Al. "The retrospective evaluation of efficacy and safety data after switching from originator rituximab to biosimilar rituximab (CT-P10) in patients diagnosed with systemic lupus erythematosus: a single-center experience." European Review for Medical and Pharmacological Sciences , vol.28, no.10, pp.3513-3522, 2024
EKİN, A. Et Al. (2024) . "The retrospective evaluation of efficacy and safety data after switching from originator rituximab to biosimilar rituximab (CT-P10) in patients diagnosed with systemic lupus erythematosus: a single-center experience." European Review for Medical and Pharmacological Sciences , vol.28, no.10, pp.3513-3522.
@article{article, author={ALİ EKİN Et Al. }, title={The retrospective evaluation of efficacy and safety data after switching from originator rituximab to biosimilar rituximab (CT-P10) in patients diagnosed with systemic lupus erythematosus: a single-center experience}, journal={European Review for Medical and Pharmacological Sciences}, year=2024, pages={3513-3522} }